Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

Share Price is delayed by 15 minutes
Get Live Data
3.50    0.00 (0.00%)
Bid:
3.00
Ask:
4.00
Spread: 1.00 (33.333%)
Market Cap: £5.77m
NOG Live PriceLast checked at - London Stock Exchange

Intraday Nostrum Oil&gas Share Chart

Board Changes

16 Aug 2024 07:00

RNS Number : 6581A
Nostrum Oil & Gas PLC
16 August 2024
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

 

London, 16 August 2024

 

Board Changes

Nostrum Oil & Gas PLC (LSE: NOG) ("Nostrum", or the "Company" and together with its subsidiaries, the "Group"), an independent mixed-asset energy company with world-class gas processing facilities and an export hub in north-west Kazakhstan, is pleased to announce that Viktor Gladun has been appointed as a non-executive director of the the Company effective 15 August 2024.

Mr Gladun is a business manager with extensive experience in the energy sector. Viktor was the CEO and executive director on the board of directors of JKX Oil and Gas plc, a UK-headquartered hydrocarbon exploration company, from 2019 through 2022, after having served as Acting CEO of JKX during 2017-2018. Viktor also served as the CEO of JKX's Ukrainian subsidiary Poltava Petroleum Company JV from 2016-2022. Prior to that he held executive financial roles at DTEK & NIKO, a senior auditor position at TNK-BP and a tax consultant position at Arthur Andersen. Viktor is currently a non-executive director of Bank Avangard JSC and of Energy Trade Group LLC, both based in Ukraine.

The Company also announces that Martin Gudgeon, a non-executive director of the Company and a member of the Nomination and Governance Committee of the Board of Directors, has been appointed as Acting Chair of such committee. In his role as Acting Chair Martin replaces Christopher Cox, who stepped down from the Board earlier this year.

As previously announced, the Company has commenced a search for an additional independent non-executive director to be appointed to the Board, taking into consideration Nostrum's Board diversity goals, and will make any further Board announcements as appropriate.

Stephen Whyte, Chair of Nostrum's Board, said:

"Viktor brings significant oil & gas sector experience and I am delighted to welcome him to the Nostrum Board.

I would also like to thank Martin Gudgeon for agreeing to serve as Acting Chair of the Board's Nomination and Governance Committee, which will ensure that there is continuity and leadership in the conduct of the Committee's activities." 

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit https://www.nostrumoilandgas.com/  

 

Further enquiries

Nostrum Oil & Gas PLC

 

Petro Mychalkiw

Chief Financial Officer

ir@nog.co.uk 

 

Instinctif Partners - UK

Guy Scarborough

Vivian Lai

+ 44 (0) 207 457 2020

nostrum@instinctif.com

 

 About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG). The producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field, which is operated by Zhaikmunai LLP, a wholly-owned subsidiary of Nostrum Oil & Gas PLC and the sole holder of the subsoil use rights with respect to the development of the field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPAMATMTJBBBI
Date   Source Headline
1st Jun 20224:35 pmRNSPrice Monitoring Extension
31st May 20225:30 pmRNSNostrum Oil & Gas
31st May 202210:27 amRNSTransfer of Listing
24th May 20224:41 pmRNSSecond Price Monitoring Extn
24th May 20224:36 pmRNSPrice Monitoring Extension
24th May 202212:55 pmRNSTR-1: Notification of major holdings
24th May 20227:00 amRNSQ1 2022 Financial Results
16th May 20224:40 pmRNSSecond Price Monitoring Extn
16th May 20224:35 pmRNSPrice Monitoring Extension
13th May 20225:05 pmRNSNotice of Annual General Meeting
11th May 20224:25 pmRNSIssuance of Practice Statement Letter
6th May 20227:00 amRNSOperational Update for Q1 ending 31 March 2022
5th May 20227:00 amRNSFull Year Results for the Year Ending 31 Dec 2021
29th Apr 202212:38 pmRNSResults of General Meeting
29th Apr 20227:00 amRNSNotice of Revised Full Year Results Date
27th Apr 20224:40 pmRNSSecond Price Monitoring Extn
27th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:51 amRNSNotice of Revised Full Year Results Date
13th Apr 20221:46 pmRNSPublication of Circular/Notice of General Meeting
13th Apr 202210:25 amRNSProposed Restructuring & Related Party Transaction
8th Apr 20224:40 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20223:44 pmRNSRestatement of impairment charge in prior year
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
22nd Feb 20229:15 amRNSDirector Declaration
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:35 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSReceipt of Consents in respect of Solicitation
4th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSOperational Update for 4Q and FY2021
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20221:46 pmRNSConsent Solicitation relating to Senior Notes
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20225:36 pmRNSRelated Party Transaction update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 202212:26 pmRNSUpdate on accessions to lock-up agreement
5th Jan 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.